Medicare Cuts Drug Prices
Digest more
While Medicare officials work to iron out the kinks, consumers shouldn’t wait for fixes to protect themselves. Double-check all information before enrolling — and if something doesn’t add up, verify directly with the insurer. A few extra minutes now could save you thousands in uncovered medical bills later.
The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.
The two-month reprieve extends through January 2026. While some providers are restarting telehealth services, it remains unclear whether eligible virtual care reimbursements, accrued during the 43-day shutdown,
In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a multi-billion-dollar government
Drastic changes to Medicare and Medicaid have made doing nothing during the 2025 open enrollment period (ends Dec. 7) especially risky.
The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK Plc’s asthma drug Trelegy Ellipta will face a 73% drop.